Consort Medical plc (CSRMY) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research downgraded shares of Consort Medical plc (NASDAQ:CSRMY) from a buy rating to a hold rating in a research note published on Tuesday morning.

According to Zacks, “Consort Medical Plc engages in the design, development, manufacture and sale of medical drug delivery devices. It operates through the Bespak and Aesica segments. Bespak segment develops and produces drug delivery devices which serves pharmaceutical companies with inhaler and auto-injector technologies. Aesica segment is a contract development and manufacturing organization which serves pharmaceutical firms with active pharmaceutical ingredient and finished dose formulation development and manufacturing services. Consort Medical Plc is headquartered in Hemel Hempstead, United Kingdom. “

Shares of Consort Medical plc (NASDAQ CSRMY) opened at 15.00 on Tuesday. The firm has a 50-day moving average price of $14.62 and a 200-day moving average price of $13.64. Consort Medical plc has a 1-year low of $12.90 and a 1-year high of $15.00. The company has a market cap of $733.70 million and a P/E ratio of 25.21.

TRADEMARK VIOLATION WARNING: “Consort Medical plc (CSRMY) Stock Rating Lowered by Zacks Investment Research” was first published by BNB Daily and is the property of of BNB Daily. If you are accessing this article on another site, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this article can be viewed at https://www.baseball-news-blog.com/2017/08/19/consort-medical-plc-csrmy-stock-rating-lowered-by-zacks-investment-research.html.

About Consort Medical plc

Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.

Get a free copy of the Zacks research report on Consort Medical plc (CSRMY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Consort Medical plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply